[Current methods of glucose metabolism control in diabetes mellitus].
The evaluation of glicometabolic control has been always considered important in the follow-up of the diabetic patient. Several methods are today available in order to register the short and long term glycaemic values. Recent studies have attributed to the post-prandial hyperglycaemias a specific role in determining the chronic complications. New pharmacological molecules are now available to reproduce the physiologic glycaemic profile.
Scarpitta
Antonietta Maria
AM
Divisione di Endocrinologia e Malattie metaboliche, Istituto di Clinica Medica, Policlinico Universitario P. Giaccone, Palermo. a.m.scarpitta@katamail.com
Sinagra
Domenico
D
D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000209:etiology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D006442:Glycated Hemoglobin / Q000032:analysis*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D008687:Metformin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D013453:Sulfonylurea Compounds